Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2014
06/26/2014US20140179675 Quinolone compound
06/26/2014US20140179670 Uracil derivative and use thereof for medical purposes
06/26/2014US20140179669 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
06/26/2014US20140179667 Aryl and heteroaryl fused lactams
06/26/2014US20140179625 Sodium channel blockers
06/26/2014US20140178349 Cycloalkyl-Substituted Imidazole Derivative
06/25/2014EP2746279A1 Fungicidal imidazolyl and triazolyl compounds
06/25/2014EP2746278A1 Substituted [1,2,4]triazole and imidazole compounds
06/25/2014EP2746277A1 Fungicidal imidazolyl and triazolyl compounds
06/25/2014EP2746276A1 New substituted triazoles and imidazoles and their use as fungicides
06/25/2014EP2746275A1 New substituted triazoles and imidazoles and their use as fungicides
06/25/2014EP2746274A1 Substituted [1,2,4]triazole compounds
06/25/2014EP2746269A1 Alicyclic[c]benzopyrone derivatives and uses thereof
06/25/2014EP2746267A2 New substituted triazoles and imidazoles and their use as fungicides
06/25/2014EP2746266A1 New substituted triazoles and imidazoles and their use as fungicides
06/25/2014EP2745691A1 Substituted imidazole compounds and their use as fungicides
06/25/2014EP2744807A1 Lysophosphatidic acid receptor antagonists
06/25/2014CN1646141B 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物 For the treatment of viral infections and abnormal cell proliferation modified nucleoside compounds
06/25/2014CN103889976A 吲唑化合物、组合物及使用方法 Indazole compounds, compositions and methods of use
06/25/2014CN103889975A 苯并咔唑化合物和包含它们的电致发光器件 Benzocarbazole compounds containing them and electroluminescent devices
06/25/2014CN103889974A 放射性标记的化合物和它们在哺乳动物中作为磷酸二酯酶(pde10a)的定量成像的放射示踪剂的用途 Radiolabeled compounds and their use as phosphodiesterase (pde10a) quantitative imaging radiotracer in a mammal The use
06/25/2014CN103889968A 氨基苯并二氢吡喃、氨基苯并二氢噻喃及氨基-1,2,3,4-四氢喹啉衍生物，包含这些化合物的药用组合物，及其在治疗中的用途 Aminochroman, amino thiochromanone and amino-1,2,3,4-tetrahydro-quinoline derivatives, pharmaceutical compositions containing these compounds, and their use in therapy
06/25/2014CN103889427A 1h-喹唑啉-2,4-二酮用于预防或治疗光敏性癫痫的应用 1h- quinazoline-2,4-dione for the prophylaxis or treatment of photosensitive epilepsy Application
06/25/2014CN103880862A 丙型肝炎病毒复制的抑制剂 Inhibitors of hepatitis C virus replication
06/25/2014CN103880827A 芳基和杂芳基取代的四氢异喹啉及其阻断去甲肾上腺素、多巴胺和血清素的重摄取的应用 Aryl and heteroaryl substituted tetrahydroisoquinoline and its application to block reuptake of norepinephrine, dopamine and serotonin
06/25/2014CN103880825A 一种高纯的三苯甲基奥美沙坦酯的制备工艺 A high purity preparation of trityl olmesartan medoxomil
06/25/2014CN103880824A 异香豆素类新抗生素和田霉素（Hetiamacin）B、C、D 及其制备和应用 Isocoumarin new class of antibiotic neomycin Wada (Hetiamacin) B, C, D and preparation and application
06/25/2014CN103880728A 一种制备二吲哚甲烷类化合物的方法 Method diindolylmethane compounds prepared
06/25/2014CN103880707A Stat3小分子抑制剂及其应用 Stat3 small molecule inhibitors and their applications
06/25/2014CN102781916B 作为缓激肽b1拮抗剂的化合物 B1 compounds as bradykinin antagonists
06/25/2014CN102686564B 吡咯烷衍生物 Pyrrolidine derivative
06/25/2014CN102627610B 一类苯并咪唑类衍生物及其应用 A class of benzimidazole derivatives and their application
06/25/2014CN102203073B 烯氨羰基化合物及其用途 Enaminocarbonyl compound and use thereof
06/25/2014CN102186821B 有含氮杂环的5环液晶化合物、液晶组成物及液晶显示元件 5-membered nitrogen-containing heterocyclic compound of the liquid crystal, the liquid crystal composition and liquid crystal display element
06/25/2014CN101970410B 吡啶基氨基乙酸化合物 Pyridylaminoacetic acid compound
06/25/2014CN101759645B p38抑制剂及它们的使用方法 p38 inhibitors and methods for their use
06/25/2014CN101503402B 2-苯胺嘧啶衍生物及其制备和用途 2-anilino-pyrimidine derivatives and their preparation and use
06/24/2014US8759519 Mono-hydrochloric salts of an inhibitor of histone deacetylase
06/24/2014US8759518 Intermediates for the preparation of HMG CoA reductase inhibitors and processes for the preparation thereof
06/24/2014US8759387 Arylalkylamine compound and process for preparing the same
06/24/2014US8759386 Pyrazole compounds as CRTH2 antagonists
06/24/2014US8759384 Oxo-imidazolyl compounds
06/24/2014US8759365 Organic compounds
06/24/2014US8759347 Inhibitors of C-FMS kinase
06/24/2014US8759335 Modulators of ATP-binding cassette transporters
06/24/2014US8759332 Hepatitis C virus inhibitors
06/19/2014WO2014093606A1 Pyridone derivatives and uses thereof in the treatment of tuberculosis
06/19/2014WO2014092514A1 Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
06/19/2014WO2014092498A1 Conjugate of vitamin c and vitamin b3, and antioxidant containing same
06/19/2014WO2014092489A1 Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient
06/19/2014WO2014092100A1 Heterocyclic compound
06/19/2014WO2014091958A1 Material for organic electroluminescent element, organic electroluminescent element, illumination device, and display device
06/19/2014WO2014091415A1 Indole carboxamide derivatives as p2x7 receptor antagonists
06/19/2014WO2014090364A1 Substituted quinones or analogues as colouring agents
06/19/2014WO2014090363A1 3-hydroxy-4-oxo-4h-pyran- or 3-hydroxy-4-oxo-1,4-dihydropyridine derivatives as protein-adhesive active substances
06/19/2014WO2014061004A3 Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof
06/19/2014WO2014049609A3 Novel salts of vilazodone
06/19/2014US20140171642 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
06/19/2014US20140171639 Trpm8 antagonists and their use in treatments
06/19/2014US20140171476 Chemical Compounds
06/19/2014US20140171469 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/19/2014US20140171446 Compounds for inflammation and immune-related uses
06/19/2014US20140171439 Inhibitors Of Histone Deacetylase
06/19/2014US20140171432 Histone demethylase inhibitors
06/19/2014US20140171420 Diazole lactams
06/19/2014US20140171363 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof
06/19/2014US20140170111 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
06/18/2014EP2742040A1 Indazole compounds, compositions and methods of use
06/18/2014EP2742030A1 1,2,4-triazolyl-substituted keto-enols
06/18/2014EP2742026A1 Sweet flavor modifier
06/18/2014EP2742025A1 Novel soft pde4 inhibitors
06/18/2014CN103874696A Quinazoline derivatives as kinases inhibitors and methods of use thereof
06/18/2014CN103874688A Herbicidal pyridazinone derivatives
06/18/2014CN103874687A Benzodioxepin-3-one compounds as dyes or as fluorescent emitters
06/18/2014CN103874684A Novel soft rock inhibitors
06/18/2014CN103874683A Novel rock kinase inhibitors
06/18/2014CN103874682A Biphenylcarboxamides as rock kinase inhibitors
06/18/2014CN103865524A Hole-type organic electroluminescent material and application thereof
06/18/2014CN103864831A Aromatic boric acid ester compound and synthetic method thereof
06/18/2014CN103864794A Method for preparing ticagrelor medicine for resisting platelet aggregation
06/18/2014CN103864770A Pyrimidinamine and pyridinamine Hedgehog signal conduction inhibitors
06/18/2014CN103864768A Ligustrazine stilbene derivatives as well as preparation method and application thereof
06/18/2014CN103864765A Benzoazepine derivative containing five-membered heterocycle as well as preparation method and application of derivative
06/18/2014CN103864764A Indazole-substituted pyrimidinamine derivative, and preparation method and use thereof
06/18/2014CN103864754A Five-membered azole heterocycle compound, preparation method, drug composition and use thereof
06/18/2014CN103864735A Synthesis of novel 5-bromo-3(2H)-benzofuranone derivatives and application in antitumor drugs
06/18/2014CN103864734A Synthesis and application of novel 4,6-dihydroxy-3(2H)-benzofuranone derivatives
06/18/2014CN102612369B Anti-tumor effect potentiator
06/18/2014CN102603695B Amino acid-fluorophore compound and application thereof
06/18/2014CN102421767B Benzofuran derivatives
06/18/2014CN102307870B Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease
06/18/2014CN102216280B Bisarylurea derivatives and their use
06/18/2014CN101405283B HIV inhibiting 5-amido substituted pyrimidines
06/17/2014US8754238 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
06/17/2014US8754226 Piperidinyl-substituted lactams as GPR119 modulators
06/17/2014US8754216 NK1 antagonists
06/17/2014US8754209 Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
06/17/2014US8754117 Pyrrolidine triple reuptake inhibitors
06/17/2014CA2699986C Anti-infective pyrimidines and uses thereof
06/17/2014CA2639936C Process for preparing aminocrotonylamino-substituted quinazoline derivatives
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 694